MKI67 and neoplasm: Treated group of mice showed lower tumor growth rates, decreased KI67 and DDX21 expression in tumors and fewer intrahepatic metastases, along with desirable accumulation of GalNAc‐FAM99B65–146 in liver tissues, but not in lungs, as well as the lack of toxicity [116].